New Delhi Mar 29 PTI An ICMR study to examine the effect of Covaxins booster dose has shown an increase in the levels of antibodies against SARS-CoV-2 Minister of State for Health Bharati Pravin Pawar told the Rajya Sabha on Tuesday International data available on booster doses of AstraZeneca and Covishield suggests a three- to four-fold increase in antibody levels after their administration Pawar said in a written reply A study has been conducted by Indian Council of Medical Research ICMR to examine the effect of booster dose of Covaxin which shows increase in the levels of neutralizing antibodies against SARS-CoV-2 after the booster dose Pawar stated As per the recommendation of the National Technical Advisory Group on Immunization NTAGI precaution dose is administered to healthcare workers frontline workers and people aged 60 years and above since January 102022 she said As on March 24 2022 221 crore precaution doses against COVID-19 have been administered PTI PLB PLB CJ CJ
\
\
